Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-26

Clinical Trial Update: Boron Neutron Capture Therapy in Treating Patients With Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating boron neutron capture therapy for melanoma (skin cancer) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Boron Neutron Capture Therapy (boron neutron capture therapy)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED